Drug Type Small molecule drug |
Synonyms Procaterol Hydrochloride, 59828-07-8, 60443-17-6 + [11] |
Target |
Action agonists |
Mechanism β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (25 Oct 1980), |
Regulation- |
Molecular FormulaC32H48Cl2N4O7 |
InChIKeyRZKAQAPBCFPJTK-RPUVXGGQSA-N |
CAS Registry81262-93-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Procaterol Hydrochloride Hydrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pulmonary Disease, Chronic Obstructive | China | 01 Jan 1993 | |
Asthma | Japan | 25 Oct 1980 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute asthma | Phase 3 | Indonesia | 01 Jun 2007 |